Related Experiment Video
Updated: Apr 30, 2026
10:25
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
Published on: March 19, 2016
9.1K
Hemostasis: old system, new players, new directions
Maureane Hoffman1, Rafal Pawlinski2
1Duke University Durham Veterans Affairs Medical Centers Durham, NC, USA.
Thrombosis Research
|April 25, 2014
Summary
Tissue factor (TF) initiates clotting for hemostasis, but its abnormal expression causes thrombosis. Other factors and cells like leukocytes also contribute to thrombosis, highlighting complex coagulation roles.
Area of Science:
- Coagulation and Thrombosis Research
- Hemostasis and Innate Immunity
Background:
- Tissue Factor (TF) and Factor VII (FVII) complex are crucial for hemostasis.
- Pathologic TF expression and contact pathway factors (FXII, FXI) contribute to thrombosis.
- Platelets, leukocytes, and red blood cells actively participate in thrombotic processes.
Discussion:
- Coagulation proteases regulate hemostasis and thrombosis via protease-activated receptors (PARs).
- TF and coagulation proteases have roles beyond hemostasis, influencing cellular responses.
- Interplay between coagulation and the innate immune system is increasingly recognized.
Key Insights:
- Novel models reveal complex mechanisms of hemostasis and thrombosis.
- Trauma-induced coagulopathy involves intricate coagulation system dysregulation.
- Contact activation pathway's pathophysiology is clarified, distinct from primary hemostasis.
Outlook:
- Further research into TF and coagulation proteases' roles in thrombosis is warranted.
- Understanding cellular participation in thrombosis may yield new therapeutic targets.
- Investigating the coagulation-innate immunity crosstalk offers insights into inflammatory diseases.
Related Concept Videos
01:05Introduction to Hemostasis
14.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.2K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
10.9K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
10.9K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:24Disorders of Hemostasis
2.7K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.7K
01:09Coagulation
8.4K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
8.4K
01:06Coagulation
1.5K
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K